These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31682903)

  • 21. Comparative Study of DSC-Based Protocols for API-Polymer Solubility Determination.
    Mathers A; Hassouna F; Klajmon M; Fulem M
    Mol Pharm; 2021 Apr; 18(4):1742-1757. PubMed ID: 33656884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the Dependence of the Flory-Huggins Interaction Parameter on Temperature and Composition in a Drug-Polymer System.
    Potter CB; Davis MT; Albadarin AB; Walker GM
    Mol Pharm; 2018 Nov; 15(11):5327-5335. PubMed ID: 30259745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
    Gautschi N; Bergström CA; Kuentz M
    Int J Pharm; 2016 Nov; 513(1-2):164-174. PubMed ID: 27609663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study.
    Iemtsev A; Hassouna F; Mathers A; Klajmon M; Dendisová M; Malinová L; Školáková T; Fulem M
    Int J Pharm; 2020 Nov; 589():119845. PubMed ID: 32931845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation.
    Haddadin R; Qian F; Desikan S; Hussain M; Smith RL
    Pharm Dev Technol; 2009; 14(1):18-26. PubMed ID: 18825543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Solubilization by Means of a Surface-Modified Edible Biopolymer Enabled by Hot Melt Extrusion.
    Ong HJ; Pinal R
    J Pharm Sci; 2018 Jan; 107(1):402-411. PubMed ID: 29074381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.
    Paus R; Ji Y; Vahle L; Sadowski G
    Mol Pharm; 2015 Aug; 12(8):2823-33. PubMed ID: 26107071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
    Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A
    Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
    Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
    Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
    Bochmann ES; Neumann D; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The step-wise dissolution method: An efficient DSC-based protocol for verification of predicted API-polymer compatibility.
    Mathers A; Pechar M; Hassouna F; Fulem M
    Int J Pharm; 2023 Dec; 648():123604. PubMed ID: 37981251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
    Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
    Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of polymeric excipients on desupersaturation profiles of active pharmaceutical ingredients. 1: Polyethylene glycol.
    Schneider R; Taspinar L; Ji Y; Sadowski G
    Int J Pharm; 2020 May; 582():119317. PubMed ID: 32320721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purely Predicting the Pharmaceutical Solubility: What to Expect from PC-SAFT and COSMO-RS?
    Klajmon M
    Mol Pharm; 2022 Nov; 19(11):4212-4232. PubMed ID: 36136040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).
    Kalantri S; Vora A
    Drug Dev Ind Pharm; 2024 May; 50(5):387-400. PubMed ID: 38634708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of humidity on the phase behavior of API/polymer formulations.
    Prudic A; Ji Y; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermodynamic phase behaviour of indomethacin/PLGA formulations.
    Prudic A; Lesniak AK; Ji Y; Sadowski G
    Eur J Pharm Biopharm; 2015 Jun; 93():88-94. PubMed ID: 25791211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.